
Publish date: 13 May 2026 / Health / Author : ATH Sokren
PPM and Confirel recorded very strong growth in the first quarter of 2026, as noted with satisfaction at the Group Executive Committee meeting held on April 29 at the Penh House Hotel. According to the Chief Financial Officer, the Group grew by 41% compared with the same period last year. Thanks to these results, PPM in French‑speaking Africa has entered the Top 10 laboratories in the same product category, ahead of Sanofi, which ranks 12th. Confirel also delivered a strong performance, with growth of 36% in the local market and 200% in exports.
Dr. Hay Ly Eang, founder and chairman of the PPM‑Confirel Group, stressed that PPM has now achieved its goal and asserted its identity thanks to the export market. For Confirel, by contrast, the journey is only halfway through, even though the company’s vision and concept show that it is on the right track.
“The concept, products and identity of Confirel are recognized internationally,” said Dr. Hay, adding that it is important to pursue this roadmap focused on sustainable development and the circular economy. According to him, Japan and South Korea are showing strong interest in Confirel’s products and recognize their value. Japan has been closely following Confirel for the past five years.
However, Dr. Hay acknowledged that, after conducting an in‑depth diagnostic, Confirel lacks human resources, particularly to transfer its know‑how and ensure coordination of the production chain. Despite these challenges, Dr. Hay remains optimistic and harbors a strong ambition: to realize his vision for Confirel by passing on his know‑how to his successor within five years, in order to meet the needs of the international market. “On their own, the Japanese and South Korean markets are 150 times larger than Cambodia’s,” he points out.